Dr Sanish Davis has been in the Clinical Research industry for over 14 years and has worked on both sides of the fence - in academia as well as in the Pharmaceutical Industry. He is currently Head, GCTO Covance India and Senior Medical Director, Cardiovascular, Metabolism & Endocrine portfolio globally for Covance Drug Development Services (a division of Lab Corp.) He has experience in managing early and late phase clinical development in both Indian as well MNC Pharma R&D environments in NCE, Innovative generics and Branded Generics space. He has worked in the domains of clinical development & Regulatory strategy for the development of compounds for Emerging markets. He has an active interest in external environment shaping activities in clinical research and in operationalizing “ethics” in Industry research. He is also General Secretary of Indian Society for Clinical Research (ISCR) for 2017-19. He has a Postdoctoral degree in Clinical Pharmacology (D.M) and postgraduate and graduate degrees in Pharmacology and Medicine (M.D). He is also a Fellow of the American College of Clinical Pharmacology (FCP).
Sanish is actively involved in training clinical research professionals of the future through his association with the Maharashtra University of Health Sciences, Nashik, Indian Society of Clinical Research, Rashtriya Uchchatar Shiksha Abhiyan (RUSA), Govt. of Maharashtra, South Asian Chapter of American College of Clinical Pharmacology and Academy of Clinical Excellence at Bombay College of Pharmacy.